Free Trial

Brokerages Set Owens & Minor, Inc. (NYSE:OMI) PT at $18.50

Owens & Minor logo with Medical background

Shares of Owens & Minor, Inc. (NYSE:OMI - Get Free Report) have been assigned an average rating of "Hold" from the eight ratings firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $18.50.

A number of equities analysts recently issued reports on the stock. Citigroup lowered their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research report on Tuesday, November 5th. Robert W. Baird lowered their price target on shares of Owens & Minor from $19.00 to $14.00 and set a "neutral" rating for the company in a report on Tuesday, November 5th. Barclays cut their price objective on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a report on Tuesday, November 5th. Finally, UBS Group reduced their price objective on Owens & Minor from $28.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, November 5th.

Read Our Latest Report on Owens & Minor

Owens & Minor Price Performance

Shares of OMI traded up $0.24 during midday trading on Wednesday, hitting $14.98. The company's stock had a trading volume of 390,343 shares, compared to its average volume of 658,583. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor has a one year low of $11.42 and a one year high of $28.35. The stock has a market capitalization of $1.16 billion, a price-to-earnings ratio of -23.05, a price-to-earnings-growth ratio of 0.48 and a beta of 0.46. The company's fifty day simple moving average is $13.29 and its two-hundred day simple moving average is $14.19.

Owens & Minor (NYSE:OMI - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.41 by $0.01. The firm had revenue of $2.72 billion for the quarter, compared to analysts' expectations of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The business's revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.44 earnings per share. As a group, equities analysts expect that Owens & Minor will post 1.49 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares of the company's stock, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 3.59% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Owens & Minor

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. DekaBank Deutsche Girozentrale raised its holdings in Owens & Minor by 76.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $43,000 after purchasing an additional 1,356 shares during the last quarter. Arizona State Retirement System increased its position in shares of Owens & Minor by 7.7% during the second quarter. Arizona State Retirement System now owns 20,371 shares of the company's stock worth $275,000 after buying an additional 1,449 shares during the period. Quarry LP raised its stake in Owens & Minor by 290.1% during the second quarter. Quarry LP now owns 2,099 shares of the company's stock worth $28,000 after buying an additional 1,561 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in Owens & Minor by 4.9% during the second quarter. The Manufacturers Life Insurance Company now owns 36,366 shares of the company's stock worth $491,000 after buying an additional 1,709 shares during the last quarter. Finally, Blue Trust Inc. lifted its holdings in Owens & Minor by 176.8% in the third quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock valued at $44,000 after buying an additional 1,780 shares during the period. 98.04% of the stock is owned by institutional investors and hedge funds.

Owens & Minor Company Profile

(Get Free Report

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

See Also

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines